On March 2, the FTSE Russell Day announced the results of the quarterly audit changes of the FTSE China A50 and other indices. Read More >

One of the most promising avenues in treating cancer is to restore our immune system’s ability to recognize and attack cancerous cells. Read More >

AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announce that Dr. Marina Bibikova has come on board as Chief Scientific Officer (CSO). ... Read More >

Moderna and Thermo Fisher Scientific Inc.announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax®, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline.... Read More >

Belgian diagnostics firm MDxHealth on Wednesday reported a 20 percent year-over-year increase in revenues for 2021 on higher demand for its ConfirmMDx prostate cancer test.... Read More >

Lucid Diagnostics on Thursday announced that its LucidDx Labs subsidiary has acquired certain licenses and other related assets from ResearchDx enabling it to operate a new CLIA-certified, CAP-accredited clinical laboratory in Lake Forest, California.... Read More >

Today, Beckman Coulter announced that Dr. Tiffany Jiang, Senior Vice President & General Manager, retired early effective February 28. Read More >

New research led by Queen Mary University of London and Barts Health NHS Trust suggests that biochemical analysis of brain tissue could be used for diagnosis and prognosis of severe traumatic brain injury (TBI) to improve patient outcomes and save billions in future clinical tria... Read More >

On March 2，BioMérieux reported that its fourth quarter revenues rose 8 percent year over year. Read More >

Veracyte reported after the close of the market on Monday that its fourth quarter revenues nearly doubled year over year. Read More >